1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL CELL HARVESTING MARKET, BY HARVESTING TYPE
5.1. Introduction
5.2. Manual Cell Harvesting
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Automated Cell Harvesting
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
6. GLOBAL CELL HARVESTING MARKET, BY STEM CELL TYPE
6.1. Introduction
6.2. Umbilical Cord Stem Cells
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Adult Stem Cells
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
6.4. Fetal Stem Cells
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
6.4.3. Geographic Lucrativeness
6.5. Embryonic Stem Cells
6.5.1. Market Opportunities and Trends
6.5.2. Growth Prospects
6.5.3. Geographic Lucrativeness
6.6. Others
6.6.1. Market Opportunities and Trends
6.6.2. Growth Prospects
6.6.3. Geographic Lucrativeness
7. GLOBAL CELL HARVESTING MARKET, BY APPLICATION
7.1. Introduction
7.2. Cancer
7.2.1. Market Opportunities and Trends
7.2.2. Growth Prospects
7.2.3. Geographic Lucrativeness
7.3. Blood Disorder
7.3.1. Market Opportunities and Trends
7.3.2. Growth Prospects
7.3.3. Geographic Lucrativeness
7.4. Genetic Disorder
7.4.1. Market Opportunities and Trends
7.4.2. Growth Prospects
7.4.3. Geographic Lucrativeness
7.5. Others
7.5.1. Market Opportunities and Trends
7.5.2. Growth Prospects
7.5.3. Geographic Lucrativeness
8. GLOBAL CELL HARVESTING MARKET, BY END USERS
8.1. Introduction
8.2. Biotechnology & Biopharmaceutical Companies
8.2.1. Market Opportunities and Trends
8.2.2. Growth Prospects
8.2.3. Geographic Lucrativeness
8.3. Hospitals
8.3.1. Market Opportunities and Trends
8.3.2. Growth Prospects
8.3.3. Geographic Lucrativeness
8.4. Research Centers
8.4.1. Market Opportunities and Trends
8.4.2. Growth Prospects
8.4.3. Geographic Lucrativeness
9. GLOBAL CELL HARVESTING MARKET, BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Harvesting Type
9.2.2. By Stem Cell Type
9.2.3. By Application
9.2.4. By End Users
9.2.5. By Country
9.2.5.1. USA
9.2.5.1.1. Market Opportunities and Trends
9.2.5.1.2. Growth Prospects
9.2.5.2. Canada
9.2.5.2.1. Market Opportunities and Trends
9.2.5.2.2. Growth Prospects
9.2.5.3. Mexico
9.2.5.3.1. Market Opportunities and Trends
9.2.5.3.2. Growth Prospects
9.3. South America
9.3.1. By Harvesting Type
9.3.2. By Stem Cell Type
9.3.3. By Application
9.3.4. By End Users
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.1.1. Market Opportunities and Trends
9.3.5.1.2. Growth Prospects
9.3.5.2. Argentina
9.3.5.2.1. Market Opportunities and Trends
9.3.5.2.2. Growth Prospects
9.3.5.3. Others
9.3.5.3.1. Market Opportunities and Trends
9.3.5.3.2. Growth Prospects
9.4. Europe
9.4.1. By Harvesting Type
9.4.2. By Stem Cell Type
9.4.3. By Application
9.4.4. By End Users
9.4.5. By Country
9.4.5.1. United Kingdom
9.4.5.1.1. Market Opportunities and Trends
9.4.5.1.2. Growth Prospects
9.4.5.2. Germany
9.4.5.2.1. Market Opportunities and Trends
9.4.5.2.2. Growth Prospects
9.4.5.3. Spain
9.4.5.3.1. Market Opportunities and Trends
9.4.5.3.2. Growth Prospects
9.4.5.4. France
9.4.5.4.1. Market Opportunities and Trends
9.4.5.4.2. Growth Prospects
9.4.5.5. Others
9.4.5.5.1. Market Opportunities and Trends
9.4.5.5.2. Growth Prospects
9.5. Middle East and Africa
9.5.1. By Harvesting Type
9.5.2. By Stem Cell Type
9.5.3. By Application
9.5.4. By End Users
9.5.5. By Country
9.5.5.1. UAE
9.5.5.1.1. Market Opportunities and Trends
9.5.5.1.2. Growth Prospects
9.5.5.2. Saudi Arabia
9.5.5.2.1. Market Opportunities and Trends
9.5.5.2.2. Growth Prospects
9.5.5.3. Others
9.5.5.3.1. Market Opportunities and Trends
9.5.5.3.2. Growth Prospects
9.6. Asia Pacific
9.6.1. By Harvesting Type
9.6.2. By Stem Cell Type
9.6.3. By Application
9.6.4. By End Users
9.6.5. By Country
9.6.5.1. Japan
9.6.5.1.1. Market Opportunities and Trends
9.6.5.1.2. Growth Prospects
9.6.5.2. China
9.6.5.2.1. Market Opportunities and Trends
9.6.5.2.2. Growth Prospects
9.6.5.3. India
9.6.5.3.1. Market Opportunities and Trends
9.6.5.3.2. Growth Prospects
9.6.5.4. South Korea
9.6.5.4.1. Market Opportunities and Trends
9.6.5.4.2. Growth Prospects
9.6.5.5. Taiwan
9.6.5.5.1. Market Opportunities and Trends
9.6.5.5.2. Growth Prospects
9.6.5.6. Thailand
9.6.5.6.1. Market Opportunities and Trends
9.6.5.6.2. Growth Prospects
9.6.5.7. Indonesia
9.6.5.7.1. Market Opportunities and Trends
9.6.5.7.2. Growth Prospects
9.6.5.8. Others
9.6.5.8.1. Market Opportunities and Trends
9.6.5.8.2. Growth Prospects
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. PerkinElmer Inc.
11.2. Tomtec
11.3. CTIBiotech
11.4. RegenMed Systems Inc.
11.5. Aspire Medical Innovation
11.6. Sartorius AG
11.7. Terumo Corporation